Autoimmune and Chronic Inflammatory Diseases
1 clinical trials · Condition
◉ Watch Autoimmune and Chronic Inflammatory Diseases
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Severe Renal Impairment Compared to Matched Healthy Participants. (NCT07032272) | Novartis Pharmaceuticals | 2025-07-23 |
Track Autoimmune and Chronic Inflammatory Diseases automatically
Every clearance here is in the API, with alerts when new ones post.